Mr. Hedt is the Chief Business Strategy Officer of Perspective Therapeutics and was the CBSO of one of its predecessors, Viewpoint Molecular Targeting.  He was previously at Clarity Pharmaceuticals where he served in a variety of leadership roles focused on novel radiopharmaceutical products. His career prior to that spanned translational development of vaccines, antibodies and small molecules primarily in oncology. He has worked in drug development consulting and for global pharmaceutical companies such as CSL and Servier, and also for a variety of biotechnology start-ups.

Mr. Hedt holds a BA degree in neuroscience from the Swinburne University of Technology, and post graduate qualifications in the History and Philosophy of Science.